MENU
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$298.24
Change
+$1.39 (+0.47%)
Capitalization
151.69B

AMGN Amgen Forecast, Technical & Fundamental Analysis

Amgen is a leader in biotechnology-based human therapeutics... Show more

Industry: #Biotechnology
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMGN with price predictions
Jul 03, 2025

Momentum Indicator for AMGN turns positive, indicating new upward trend

AMGN saw its Momentum Indicator move above the 0 level on July 02, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMGN's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on July 02, 2025. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

AMGN moved above its 50-day moving average on July 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AMGN crossed bullishly above the 50-day moving average on June 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 222 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AMGN's P/B Ratio (24.331) is slightly higher than the industry average of (5.632). P/E Ratio (22.661) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (2.526) is also within normal values, averaging (3.004). Dividend Yield (0.031) settles around the average of (0.161) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (3.643).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMGN is expected to report earnings to rise 6.73% to $5.23 per share on August 05

Amgen AMGN Stock Earnings Reports
Q2'25
Est.
$5.23
Q1'25
Beat
by $0.61
Q4'24
Beat
by $0.27
Q3'24
Beat
by $0.47
Q2'24
Missed
by $0.01
The last earnings report on May 01 showed earnings per share of $4.90, beating the estimate of $4.29. With 1.52M shares outstanding, the current market capitalization sits at 151.69B.
A.I.Advisor
published Dividends

AMGN paid dividends on June 06, 2025

Amgen AMGN Stock Dividends
А dividend of $2.38 per share was paid with a record date of June 06, 2025, and an ex-dividend date of May 16, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMFM26.930.28
+1.04%
Motley Fool Mid-Cap Growth ETF
TOGA34.780.26
+0.75%
Tremblant Global ETF
ARP28.680.04
+0.14%
PMV Adaptive Risk Parity ETF
IQLT43.180.04
+0.09%
iShares MSCI Intl Quality Factor ETF
PAXS15.150.01
+0.07%
PIMCO Access Income Fund

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.47%
PFE - AMGN
58%
Loosely correlated
+0.24%
GSK - AMGN
51%
Loosely correlated
-0.86%
GILD - AMGN
49%
Loosely correlated
+0.22%
ABBV - AMGN
48%
Loosely correlated
-0.77%
NVS - AMGN
48%
Loosely correlated
-1.54%
More